Eliana Marengo1, Diego J Martino1, Ana Igoa2, María Scápola2, Guillermo Fassi2, Mariana Urtueta Baamonde2, Sergio A Strejilevich3. 1. Bipolar Disorder Program, Institute of Neurosciences, Favaloro University, Buenos Aires, Argentina; National Council of Scientific and Technical Research (CONICET), Argentina. 2. Bipolar Disorder Program, Institute of Neurosciences, Favaloro University, Buenos Aires, Argentina. 3. Bipolar Disorder Program, Institute of Neurosciences, Favaloro University, Buenos Aires, Argentina. Electronic address: sstreji@gmail.com.
Abstract
BACKGROUND: The aim of this study was to investigate reproductive health and level of planning of pregnancies among women with bipolar disorder (BDW). METHODS: 63 euthymic women, with bipolar disorder type I, II or not otherwise specified diagnosis, were included and were matched with a control group of 63 healthy women. Demographic and clinical data, structured reproductive health measures and planning level of pregnancies were obtained and compared between groups. RESULTS: Lower level of planning of pregnancies and higher frequency of unplanned pregnancies were found among BDW. Women with bipolar disorder reported history of voluntary interruption of pregnancies more frequent than women from control group. Current reproductive health care showed no differences between groups. LIMITATIONS: Data based on self-report of participants and retrospective nature of some collected measures may be affected by information bias. The pregnancy planning measure has not been validated in this population before. Demographic and clinical characteristics of the sample study limit generalization of these findings. CONCLUSIONS: Adverse reproductive events, as unplanned pregnancies and elective interruption of pregnancies, may be more frequent among BDW. Clinician must be aware of the reproductive health during treatment of young BDW and take measures to improve better family planning access.
BACKGROUND: The aim of this study was to investigate reproductive health and level of planning of pregnancies among women with bipolar disorder (BDW). METHODS: 63 euthymic women, with bipolar disorder type I, II or not otherwise specified diagnosis, were included and were matched with a control group of 63 healthy women. Demographic and clinical data, structured reproductive health measures and planning level of pregnancies were obtained and compared between groups. RESULTS: Lower level of planning of pregnancies and higher frequency of unplanned pregnancies were found among BDW. Women with bipolar disorder reported history of voluntary interruption of pregnancies more frequent than women from control group. Current reproductive health care showed no differences between groups. LIMITATIONS: Data based on self-report of participants and retrospective nature of some collected measures may be affected by information bias. The pregnancy planning measure has not been validated in this population before. Demographic and clinical characteristics of the sample study limit generalization of these findings. CONCLUSIONS: Adverse reproductive events, as unplanned pregnancies and elective interruption of pregnancies, may be more frequent among BDW. Clinician must be aware of the reproductive health during treatment of young BDW and take measures to improve better family planning access.
Authors: Pierre-Alexandre Lasica; Nine M C Glangeaud-Freudenthal; Bruno Falissard; Anne-Laure Sutter-Dallay; Florence Gressier Journal: Arch Womens Ment Health Date: 2021-10-18 Impact factor: 3.633
Authors: Megan Krantz; Tina Goldstein; Brian Rooks; John Merranko; Fangzi Liao; Mary Kay Gill; Rasim Diler; Danella Hafeman; Neal Ryan; Benjamin Goldstein; Shirley Yen; Heather Hower; Jeffrey Hunt; Martin Keller; Michael Strober; David Axelson; Boris Birmaher Journal: J Am Acad Child Adolesc Psychiatry Date: 2017-11-26 Impact factor: 8.829
Authors: Jacqueline Frayne; Yvonne Hauck; Thinh Nguyen; Helena Liira; Vera A Morgan Journal: Scand J Prim Health Care Date: 2021-02-11 Impact factor: 2.581
Authors: Vanessa W S Ng; Kenneth K C Man; Le Gao; Esther W Chan; Edwin H M Lee; Joseph F Hayes; Ian C K Wong Journal: Pharmacoepidemiol Drug Saf Date: 2021-07-08 Impact factor: 2.732